REN and obesity due to melanocortin 4 receptor deficiency: The results of the potential interaction of allopurinol use with sex, age, obesity, antecedents of atherothrombotic disease, diabetes, and concurrent use of statins or drugs blocking the renin-angiotensin system are shown in Figure 5.